Connection
Sidney Keisner to Humans
This is a "connection" page, showing publications Sidney Keisner has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.128 |
|
|
|
-
Keisner SV. Prevention of Skeletal-Related Events With Extended-Interval Denosumab: A Review of the Literature. Ann Pharmacother. 2024 Feb; 58(2):174-184.
Score: 0.036
-
Keisner SV. Rucaparib and olaparib for the treatment of prostate cancer: A clinician's guide to choice of therapy. J Oncol Pharm Pract. 2022 Oct; 28(7):1624-1633.
Score: 0.034
-
Casserly EA, Rogers SE, Keisner SV. Lack of interaction between enzalutamide and warfarin in a metastatic castration-resistant prostate cancer patient. J Oncol Pharm Pract. 2017 Jan; 23(1):68-70.
Score: 0.023
-
Keisner SV, Shah SR. Pazopanib: the newest tyrosine kinase inhibitor for the treatment of advanced or metastatic renal cell carcinoma. Drugs. 2011 Mar 05; 71(4):443-54.
Score: 0.016
-
Keisner SV, Shah SR, Jean GW, Ussery SM, Dowell JE. Retrospective analysis of the consequences of acid suppressive therapy on ketoconazole efficacy in advanced castration-resistant prostate cancer. Ann Pharmacother. 2010 Oct; 44(10):1538-44.
Score: 0.015
-
Shah SR, Jean GW, Keisner SV, Ussery SM, Dowell JE. Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid. Support Care Cancer. 2012 Jan; 20(1):87-93.
Score: 0.004